跳至主要内容
临床试验/CTRI/2023/03/050527
CTRI/2023/03/050527尚未招募Unknown

A clinical trial to evaluate the safety and efficacy of TATC/HT/001 as a treatment modality in hyperthyroidism. - Nil

Ayurgenics Ayurveda Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult males or females,greater than or equal to 18yr age with a diagnosis of Gravesâ??disease ( Hyperthyroidism)
  • 2.Gravesâ?? disease (Hyperthyroidism) defined as raised T4 and/or T3
  • 3.low TSH with or without hypermetabolic symptoms

排除标准

  • Pregnancy/planning pregnancy in next 01 yr, use of Antithyroid drugs, iodine containing drugs, Multinodular goiter, thyroid malignancy/suspicious nodules, significant eye disease, Refusal to give consent

研究者

发起方
Ayurgenics Ayurveda Private Limited

相似试验